ABBV·Healthcare·Dividend Aristocrats
AbbVie Earnings +4.5% Surge After Bullish Upgrade Shock
Are AbbVie Earnings and a surprise Bank of America upgrade signaling a new phase in the pharma giant’s post-Humira transition?…
Dividend Aristocrats
ABBV·Healthcare·Dividend Aristocrats
CAT·Industrials·Dividend Aristocrats
Caterpillar Earnings Q1: Record Boom Fueled by AI Power
Are Caterpillar Earnings quietly becoming one of the biggest AI infrastructure winners on Wall Street? Maik Kemper Editor in Chief…
KO·Consumer Defensive·Dividend Aristocrats
Coca-Cola Earnings +6.3% Surge After Record Q1 Beat
Can the latest Coca-Cola Earnings beat and guidance hike finally turn this defensive dividend icon into a market-beating growth story…
IBM·Technology·Dividend Aristocrats
IBM Earnings -8.3% Plunge: Strong Q1 Beat, AI Shock
IBM Earnings beat expectations, so why did the stock suddenly plunge as investors questioned the company’s AI and software momentum?…
LOW·Consumer Cyclical·Dividend Aristocrats
Lowe’s Earnings -1.9% Warning: Is the Dividend King Still Safe?
Can Lowe’s Earnings and its dividend powerhouse status offset a shaky housing market and a -1.9% share price move? Maik…
TGT·Consumer Defensive·Dividend Aristocrats
Target CEO Change: Can Fidelke’s Cost Push Stick?
Can the Target CEO Change really fix margins and revive the “cheap chic” magic investors fell in love with? Maik…
CAT·Industrials·Dividend Aristocrats
Caterpillar Energy Strategy: +2.8% Surge on AI and LNG Power Bet
Is the Caterpillar Energy Strategy turning a cyclical machinery name into a structural winner of the AI and LNG power…
PEP·Consumer Defensive·Dividend Aristocrats
PepsiCo Earnings +2.9% Surge as Margin Power Returns
Can PepsiCo’s surprise margin rebound and snack price cuts really justify the latest earnings-driven surge in the stock? Maik Kemper…
XOM·Energy·Dividend Aristocrats
Exxon Mobil Strategy Boom With Deepwater Bets And Cash Flow
Can Exxon Mobil Strategy really justify tech-like valuations by leaning on deepwater exploration, high oil prices and relentless dividend power?…
JNJ·Healthcare·Dividend Aristocrats
Johnson & Johnson Earnings +9.9% Surge With Dividend Hike
Can Johnson & Johnson’s latest earnings surge and dividend hike still justify its premium valuation for long-term investors? Maik Kemper…